A Phase I Study of PS-341 in Combination With 5-FU/LV in Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2013
At a glance
- Drugs Bortezomib (Primary) ; Fluorouracil; Folinic acid
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- 05 Jan 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2007 Status changed from completed to in progress.